ANALYSIS OF THE EFFECT OF GALANTAMINE IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE (AD)

被引：0

作者：

Moruzzi, E. ^{[1
]}

机构：

[1] Voila Hosp, Campina, Romania

来源：

EUROPEAN PSYCHIATRY | 2012年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

P-455

引用

页数：1

共 50 条

[41] Galantamine hydrobromide in a treatment of Alzheimer's disease
Nikolova, G
Yancheva, S
Raychev, I
Dobreva, D
Traykov, L
NEUROBIOLOGY OF AGING, 2002, 23 (01) : S96 - S96
[42] The final dose of galantamine in the treatment of mild to moderate Alzheimer's disease is in a naturalistic environment influenced by physicians' subjective evaluation of patients' status
Kogoj, A.
Denislic, M.
Ambrozic, D.
Hren, R.
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 190 - 191
[43] Economic and clinical benefits of galantamine in the treatment of mild to moderate Alzheimer's disease in a Korean population: A 52-week prospective study
Suh, Guk-Hee
Jung, Hee Yeon
Lee, Chang Uk
Choi, Sungku
JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (01) : 10 - 17
[44] Galantamine improves non-cognitive symptoms as compared to nootropics in outpatients with mild to moderate Alzheimer's disease
Ibach, B.
Kuehn, F.
Gerwe, M.
Diekamp, B.
PHARMACOPSYCHIATRY, 2009, 42 (05) : 224 - 224
[45] Efficacy of once-daily galantamine extended-release in patients with mild to moderate Alzheimer's disease
Brodaty, H
Yan, B
Damaraju, CRV
NEUROLOGY, 2004, 62 (07) : A317 - A318
[46] Safety and tolerability of once-daily galantamine extended release in patients with mild to moderate Alzheimer's disease
Brodaty, H
Schwalen, S
Gold, M
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S209 - S209
[47] Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease
Grossberg, G. T.
Sadowsky, C.
Olin, J. T.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 651 - 660
[48] EVALUATION OF THE COST EFFECTIVENESS OF THE TREATMENT OF MILD AND MODERATE ALZHEIMER'S DISEASE
Langsch, L. R.
VALUE IN HEALTH, 2017, 20 (09) : A860 - A860
[49] Effect of Galantamine on Caregiver Time and Activities of Daily Living in Mild to Moderate Alzheimer's Disease: A 1-Year Prospective Study
Suh, Guk-Hee
Jung, Hee Yeon
Lee, Chang Uk
Lee, Sang Kyu
Lee, Nam-Jin
Kim, Jae Hyun
Kee, Baik Seok
Ko, Dae Gwan
Kim, Young-Hoon
Hong, In Ja
Choi, Sungku
Gold, Michael
ANNALS OF GERIATRIC MEDICINE AND RESEARCH, 2007, 11 (02): : 74 - 82
[50] Safety and efficacy of galantamine in mild to moderate Alzheimer's disease. A naturalistic, observational cohort survey: Allcare
Pellerin, J
Cnockaert, X
Fasanaro, A
Tessier, C
Foucher, A
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S209 - S210

← 1 2 3 4 5 →